[PDF][PDF] Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low …
M Mráz, Z Lacinová, P Kaválková, D Haluzikova… - Physiol Res, 2011 - biomed.cas.cz
M Mráz, Z Lacinová, P Kaválková, D Haluzikova, P Trachta, J Drapalova, V Hanušová…
Physiol Res, 2011•biomed.cas.czSerum Concentrations of Fibroblast Growth Factor 19 in Patients With Obesity and Type 2
Diabetes Mellitus: the Influence of Acut Page 1 PHYSIOLOGICAL RESEARCH • ISSN 0862-8408(print)
• ISSN 1802-9973(online) © 2011 Institute of Physiology vvi, Academy of Sciences of the
Czech Republic, Prague, Czech Republic Fax +420 241 062 164, e-mail: physres@biomed.cas.cz,
www.biomed.cas.cz/physiolres Physiol. Res. 60: 627-636, 2011 Serum Concentrations of
Fibroblast Growth Factor 19 in Patients With Obesity and Type 2 Diabetes Mellitus: the …
Diabetes Mellitus: the Influence of Acut Page 1 PHYSIOLOGICAL RESEARCH • ISSN 0862-8408(print)
• ISSN 1802-9973(online) © 2011 Institute of Physiology vvi, Academy of Sciences of the
Czech Republic, Prague, Czech Republic Fax +420 241 062 164, e-mail: physres@biomed.cas.cz,
www.biomed.cas.cz/physiolres Physiol. Res. 60: 627-636, 2011 Serum Concentrations of
Fibroblast Growth Factor 19 in Patients With Obesity and Type 2 Diabetes Mellitus: the …
Summary
The aim of our study was to measure serum concentrations of fibroblast growth factor 19 (FGF-19) in patients with obesity
biomed.cas.cz
